Table 3.
The revised ISSHP criteria of preeclampsia [8, 9] in women with singleton pregnancy and early- or late-onset preeclampsia.
| Criterion | EOP (n = 113) | LOP (n = 101) | Total (n = 214) | p |
|---|---|---|---|---|
| Proteinuria | 113 (100.0) | 101 (100.0) | 214 (100.0) | ns |
| Renal insufficiency (creatinine >90 μmol/L), n (%) | 11 (9.7) | 6 (6.0) | 17 (7.9) | ns |
| Liver involvement, n (%) | 15 (13.3) | 8 (7.9) | 23 (10.7) | ns |
| Neurological complications, n (%) | 20 (17.7) | 8 (8.0) | 28 (13.0) | 0.0342 |
| Hematological complications, n (%) | 50 (44.2) | 35 (34.6) | 85 (39.7) | ns |
| (i) Thrombocytopenia, n (%) | 37 (74) | 29 (82.8) | 66 (77.6) | ns |
| (ii) DIC, n (%) | 0 (0.0) | 2 (5.8) | 2 (2.4) | ns |
| (iii) Hemolysis, n (%) | 13 (26) | 4 (11.4) | 17 (20.0) | 0.0416 |
| FGR, n (%) | 80 (70.7) | 49 (48.5) | 129 (60.3) | 0.0009 |
DIC, disseminated intravascular coagulation; EOP, early-onset preeclampsia; FGR, fetal growth restriction; ISSHP, International Society for the Study of Hypertension in Pregnancy; LOP, late-onset preeclampsia; ns, nonstatistically significant.